Hospital to host Parkinson's trial

9 October 2013 Last updated at 11:57 ET

Please turn on JavaScript. Media requires JavaScript to play.

The study aims to test a new technique for treating Parkinson's disease

A pilot into the treatment of Parkinson's disease which researchers hope could help to slow down the condition is taking place in Bristol.

Frenchay Hospital wants to discover the effect of infusing the protein Glial Cell Line-Derived Neurotrophic Factor (GDNF) directly into the brain.

The pilot follows an "initial safety trial" involving six patients.

The project is funded by Parkinson's UK, with support from Cure Parkinson's Trust and North Bristol NHS Trust.

The study will research if GDNF infusion, using a "specially-designed delivery port", could help to improve symptoms such as a stiffness, slowness of movement and tremor.

Neurosurgeon Professor Steven Gill said: "One of the biggest problems facing many researchers in the past has been finding a way to get past the blood/brain barrier, which prevents materials from blood entering the brain.

"We have developed a new way to bypass this barrier, and deliver the protein directly, by infusion, to the areas of the brain where cells die in Parkinson's."

View post:
Hospital to host Parkinson's trial